A phase IIb, open-label, single-arm study of zanidatamab (ZW25) monotherapy in subjects with advanced or metastatic HER2-amplified biliary tract cancers Meeting Abstract
| Authors: | Pant, S.; Ducreux, M.; Harding, J. J.; Javle, M. M.; Oh, D. Y.; Wasan, H. S.; Fortenberry, A.; Josephson, N. C.; Mwatha, A.; Wang, K.; Fan, J. |
| Abstract Title: | A phase IIb, open-label, single-arm study of zanidatamab (ZW25) monotherapy in subjects with advanced or metastatic HER2-amplified biliary tract cancers |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800037 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.TPS352 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS352 -- Source: Wos |
